首页> 外文期刊>The Journal of Urology >Re: Differential transformation capacity of Src family kinases during the initiation of prostate cancer.
【24h】

Re: Differential transformation capacity of Src family kinases during the initiation of prostate cancer.

机译:回复:前列腺癌发作期间Src家族激酶的差异转化能力。

获取原文
获取原文并翻译 | 示例
       

摘要

Src family kinases (SFKs) are pleiotropic activators that are responsible for integrating signal transduction for multiple receptors that regulate cellular proliferation, invasion, and metastasis in a variety of human cancers. Independent groups have identified increased expression of individual SFK members during prostate cancer progression, raising the question of whether SFKs display functional equivalence. Here, we show that Src kinase, followed by Fyn kinase and then Lyn kinase, exhibit ranked tumorigenic potential during both paracrine-induced and cell-autonomous-initiated prostate cancer. This quantitative variation in transformation potential appears to be regulated in part by posttranslational palmitoylation. Our data indicate that development of inhibitors against specific SFK members could provide unique targeted therapeutic strategies.
机译:Src家族激酶(SFK)是多效性激活剂,负责整合多种受体的信号转导,这些受体调节多种人类癌症中的细胞增殖,侵袭和转移。独立小组已确定在前列腺癌进展过程中单个SFK成员的表达增加,这引发了SFK是否显示功能对等的问题。在这里,我们显示Src激酶,然后是Fyn激酶,然后是Lyn激酶,在旁分泌诱导的和细胞自主引发的前列腺癌中均表现出排名的致瘤潜力。转化潜力的这种定量变化似乎部分受翻译后棕榈酰化作用的调节。我们的数据表明,针对特定SFK成员的抑制剂的开发可以提供独特的靶向治疗策略。

著录项

  • 来源
    《The Journal of Urology》 |2011年第6期|共1页
  • 作者

    Atala A;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 15:17:06

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号